Replies to post #222919 on Biotech Values

[ghmm]

TRIL:

At these prices, an ATM is pretty worthless with the kind of money they need to advance one path forward much less multiple!

I've been fearing a rights offering which seems more popular in Canada but even that now may be hard to raise enough at these levels! So hopefully it finally pushes management to partner or sell out! Would like to see a 13D with some comments about pushing a vote on strategic alternatives.